256 related articles for article (PubMed ID: 9512702)
1. [SMANCS-TAE combined with PEI in the treatment for hepatocellular carcinoma].
Numata K; Tanaka K; Kiba T; Saito S; Morita K; Kitamura T; Kondo M; Morimoto M; Shirato K; Hori A; Shimamura T; Isozaki T; Arata S; Okazaki H; Fujii T; Sekihara H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():141-5. PubMed ID: 9512702
[TBL] [Abstract][Full Text] [Related]
2. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
3. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI].
Shimizu T; Endou H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693
[TBL] [Abstract][Full Text] [Related]
4. [Efficiency of segmental SMANCS/Lip-TAE for hepatocellular carcinoma--comparative studies in the efficacy of segmental SMANCS/Lip-TAI].
Matoba M; Mitsuya T; Ichiyanagi K; Morita M; Kidani E; Ibe N; Tatsumi Y; Tamamura H; Nakagawa T; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1997 Jan; 24(1):37-42. PubMed ID: 9020943
[TBL] [Abstract][Full Text] [Related]
5. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
[TBL] [Abstract][Full Text] [Related]
6. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE].
Itsubo M; Koike K; Toda G
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694
[TBL] [Abstract][Full Text] [Related]
7. [Our initial experience with SMANCS in TAE for liver cancer].
Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma].
Matoba M; Okimura T; Yamamoto I
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692
[TBL] [Abstract][Full Text] [Related]
9. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
10. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of therapeutic effects of SMANCS (+TAE) and Non-SMANCS/LpTAE].
Nabeshima M; Ochi J; Hikita H; Nishikawa H; Ohara T; Torii A; Fujita S; Takeda J; Miura K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():99-104. PubMed ID: 9512696
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
[TBL] [Abstract][Full Text] [Related]
13. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
14. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
[TBL] [Abstract][Full Text] [Related]
15. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS].
Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691
[No Abstract] [Full Text] [Related]
16. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma].
Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687
[TBL] [Abstract][Full Text] [Related]
17. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
Ihaya T; Ametani M; Matsusue E
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
[TBL] [Abstract][Full Text] [Related]
18. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
19. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
Inoue Y; Nakamura H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]